We Work for Health of New Jersey seeks to educate our elected leaders, the news media and the communities they serve about the important contributions these companies and their employees make to the health and economic security of individuals, local communities, and to the state of New Jersey. The state’s biopharmaceutical companies stand together with our business and community partners to educate elected leaders on critical public policy issues that allow our sector, and the surrounding community.
The biopharmaceutical sector is the foundation of one of New Jersey’s most dynamic innovation and business ecosystems. Not only does the industry invest heavily in the research and development of new treatments and cures, it also generates high quality jobs, powers economic output and exports for the U.S. economy and sustains a very large-scale supply chain.
Update
Read our statement of opposition on HR 3 and other drug pricing proposals.
Learn about the economic impact of HR 3 and drug pricing proposals in New Jersey.
Supporting High Quality Jobs in New Jersey
The innovative biopharmaceutical sector directly supported 63,415 jobs in New Jersey in 2020. These jobs are often high-skill, high-wage professions.
The industry also supported another 277,336 jobs indirectly, for a total of about 340,751 jobs across the New Jersey economy. These additional jobs are with vendors and suppliers such as construction companies and I.T. companies, and jobs generated by the sector’s employees such as day care centers and restaurants.
New Jersey workers whose jobs were supported by the biopharmaceutical sector paid a total of $7.5 billion in personal taxes in 2017—$6.6 billion in federal taxes and $913 million in state taxes.
New Jersey's Economic Impact
In 2020, the biopharmaceutical sector supported $108.3 billion in economic output for the state of New Jersey—including $51.4 billion generated directly by the sector, and another $56.9 billion through its vendors and suppliers and through the economic activity of its workforce.
vendor relationships
vendor spending
$7,920,347,489
Partners
For more information on WWFH-NJ, please contact us at info@weworkforhealth.org.
Join
Media
In her role at J&J, Dr. Nicholson develops an overarching women’s health strategy with a focus on maternal health. She has carried this torch by driving investment in policies and solutions to address the U.S. maternal mortality crisis, partnering with national maternal...
In her role at J&J, Dr. Nicholson develops an overarching women’s health strategy with a focus on maternal health. She has carried this torch by driving investment in policies and solutions to address the U.S. maternal mortality crisis, partnering with national maternal health leaders to identify and take action toward solutions. She has hosted maternal health roundtable sessions with partners such as the Centers for Disease Control and the National Birth Equity Collaborative to identify opportunities to reduce maternal mortality. She also engages in policy and advocacy efforts by educating policymakers on critical women’s health issues.
Watch the highlights from the 2018 We Work For Health Summit.
Watch the highlights from the 2018 We Work For Health Summit.
Some of our partners attended the 2017 We Work For Health Summit. Hear from some of them in our recap video.
Some of our partners attended the 2017 We Work For Health Summit. Hear from some of them in our recap video.
